Global Convalescent Plasma Therapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Antibody Type;

IgM, IgG, and IgA.

By Application;

Prophylaxis and Treatment.

By End User;

Hospitals & Clinics, and Laboratories & Research Institutes.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn752142620 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Convalescent Plasma Therapy Market (USD Million), 2021 - 2031

In the year 2024, the Global Convalescent Plasma Therapy Market was valued at USD 3.43 million. The size of this market is expected to increase to USD 9.71 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 16.0%.

The Convalescent Plasma Therapy Market is anticipated to achieve significant revenue growth and an impressive compound annual growth rate (CAGR) from 2023 to 2030. This market expansion is driven by the increasing global demand for Convalescent Plasma Therapy in both prophylaxis and treatment applications. The report provides detailed insights into the lucrative opportunities available at the country level within this market. Additionally, it offers a thorough analysis of costs, market segments, trends, regional developments, and the commercial progress of major key players worldwide during the forecast period.

This Convalescent Plasma Therapy Market report consolidates comprehensive information about the industry, encompassing both quantitative and qualitative data analysis with projections extending from 2023 to 2030. It considers various influencing factors, including product pricing, penetration levels of products or services at both country and regional scales, national GDP, market dynamics within primary and secondary markets, end-use industries, major players, consumer purchasing behavior, and the economic, political, and social conditions of different countries. The report is segmented to provide a detailed examination of the market from multiple perspectives.

The report's primary sections include market segments, market outlook, competitive landscape, and company profiles. Each segment offers in-depth details based on various perspectives such as end-use industry, product or service type, and other relevant criteria reflecting the current market scenario. The market outlook section provides a comprehensive analysis of market evolution, growth drivers, restraints, opportunities, and challenges. It also includes Porter’s Five Forces Framework, macroeconomic analysis, value chain analysis, and pricing analysis, all of which significantly influence the market both presently and throughout the forecast period. The section on drivers and restraints addresses internal market factors, while opportunities and challenges focus on external influences affecting the market. Moreover, the market outlook highlights trends that impact new business development and investment opportunities.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Antibody Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Convalescent Plasma Therapy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising incidence of infectious diseases
        2. Growing awareness and government support
        3. Limited treatment options for certain diseases
      2. Restraints
        1. Limited efficacy and safety concerns
        2. Stringent regulatory requirements
        3. Logistics and donor availability
      3. Opportunities
        1. Technological advancements
        2. Development of new applications
        3. Increasing focus on personalized medicine
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Convalescent Plasma Therapy Market, By Antibody Type, 2021 - 2031 (USD Million)
      1. IgM
      2. IgG
      3. IgA
    2. Global Convalescent Plasma Therapy Market, By Application, 2021 - 2031 (USD Million)
      1. Prophylaxis
      2. Treatment
    3. Global Convalescent Plasma Therapy Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics
      2. Laboratories & Research institutes
    4. Global Convalescent Plasma Therapy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Bio Farma
      2. Grifols
      3. Hilton Pharma
      4. Biotest
      5. BPL
  7. Analyst Views
  8. Future Outlook of the Market